NanoCarrier Employee Directory

NanoCarrier corporate office is located in 144-15 Chuou Wakashiba Kashiwa, Wakashiba, Chiba, 277-0871, Japan and has 51-200 employees.

Key Employees of NanoCarrier

NanoCarrier Global Presence

globalPresence illustration
Asia1-10

Index of contact profiles from NanoCarrier

Hundreds of professionals searching for NanoCarrier have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at NanoCarrier

Explore people who held key positions, contributed to NanoCarrier's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Japan

Frequently Asked Questions Regarding NanoCarrier Employees

How many employees does NanoCarrier have?
NanoCarrier has 51-200 employees
Who is the CFO of NanoCarrier?
NanoCarrier’s CFO is Tetsuhito Matsuyama
Who are NanoCarrier key employees?
Some of NanoCarrier key employees are Tetsuhito Matsuyama, Hiroyuki Hanada
Where is NanoCarrier located?
NanoCarrier’s headquarters are located at 144-15 Chuou Wakashiba Kashiwa, Wakashiba, Chiba, 277-0871, Japan
How do I contact NanoCarrier?
NanoCarrier Contact Info: Phone number: +81 471977621 Website: www.nanocarrier.co.jp
What does NanoCarrier do?

NanoCarrier's key business objective is to deliver new pharmaceuticals primarily in the area of cancer to society through our pioneer work of micellar nanoparticle technology as core technology developed based on nanotechnology, which originates in Japan. NanoCarrier is strongly committed to research and development through which we strive to devel... op cutting-edge pharmaceuticals to meet the needs of many patients suffering from cancer. Conventional anticancer agents show similar cytotoxic effects on cancerous and normal cells. The administration of these agents generally causes adverse reactions because it is distributed to the entire body, affecting normal cells as well. NanoCarrier's pharmaceutical products, using the micellar nanoparticle technology, are expected to wide therapeutic window of given such agent to accumulate more in cancerous lesions, thereby reducing drug distribution to normal cells, and reducing the occurrence of adverse reactions. It has been observed by ongoing Phase 1 trough Phase 3 clinical trials.Read More

Is NanoCarrier a public company?
Yes, NanoCarrier is a public company and is traded under the symbol 4571
See more information about NanoCarrier Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.